The Bilirubin Albumin Ratio in the Management of Hyperbilirubinemia in Preterm Infants to Improve Neurodevelopmental Outcome: A Randomized Controlled Trial - BARTrial

Christian V. Hulzebos, Peter H. Dijk, Deirdre E. van Imhoff, Arend F. Bos, Enrico Lopriore, Martin Offringa, Selma A. J. Ruiter, Koen N. J. A. van Braeckel, Paul F. M. Krabbe, Elise H. Quik, Letty van Toledo-Eppinga, Debbie H. G. M. Nuytemans, Aleid G. van Wassenaer-Leemhuis, Manon J. N. Benders, Karen K. M. Korbeeck-van Hof, Richard A. van Lingen, Liesbeth J. M. Groot Jebbink, Djien Liem, Petri Mansvelt, Jan BuijsPaul Govaert, Ineke van Vliet, Twan L. M. Mulder, Cecile Wolfs, Willem P. F. Fetter, Celeste Laarman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article numbere99466
JournalPLOS ONE
Volume9
Issue number6
DOIs
Publication statusPublished - 13 Jun 2014

Cite this

Hulzebos, C. V., Dijk, P. H., van Imhoff, D. E., Bos, A. F., Lopriore, E., Offringa, M., Ruiter, S. A. J., van Braeckel, K. N. J. A., Krabbe, P. F. M., Quik, E. H., van Toledo-Eppinga, L., Nuytemans, D. H. G. M., van Wassenaer-Leemhuis, A. G., Benders, M. J. N., Korbeeck-van Hof, K. K. M., van Lingen, R. A., Jebbink, L. J. M. G., Liem, D., Mansvelt, P., ... Laarman, C. (2014). The Bilirubin Albumin Ratio in the Management of Hyperbilirubinemia in Preterm Infants to Improve Neurodevelopmental Outcome: A Randomized Controlled Trial - BARTrial. PLOS ONE, 9(6), [e99466]. https://doi.org/10.1371/journal.pone.0099466